[PDF] Top 20 Educação global no jardim-de-infância: um projeto sobre os valores
Has 10000 "Educação global no jardim-de-infância: um projeto sobre os valores" found on our website. Below are the top 20 most common "Educação global no jardim-de-infância: um projeto sobre os valores".
Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosisII. MRI analysis results of a multicenter, randomized, double‐blind, placebo‐controlled trial
... Significant treatment group differences were detected between the placebo and both treatment groups for the per- cent of scans that were active (table 41, the annual rate of ac[r] ... See full document
10
Safety and efficacy of PG102P for the control of pruritus in patients undergoing hemodialysis (SNUG trial): study protocol for a randomized controlled trial
... a multicenter, randomized, double-blind, placebo- controlled trial in which one group will be treated with PG102P ...superiority trial is planned to test the ... See full document
12
Effects of Ghrelin Treatment on Exercise Capacity in Underweight COPD Patients: a substudy of a multicenter, randomized, double-blind, placebo-controlled trial of ghrelin treatment
... It should be noted that individuals in this study had different reactions to PR or ghrelin therapy. Of note, in the present study, the exercise capacity improvement by exogenous ghrelin was negatively correlated with the ... See full document
10
Current perspective on rituximab in rheumatic diseases
... Abstract: The steadily increasing knowledge regarding pathogenetic mechanisms in autoimmune rheumatic diseases has paved the way to different therapeutic approaches. In par- ticular, the market entry of biologics has ... See full document
5
Interleukin-6 inhibition for treatment of rheumatoid arthritis: A review of tocilizumab therapy
... Fully published Phase III trials are now described. Baseline data, as well as inclusion and exclusion criteria, for each study are summarized in Tables 1 and 2. Some of the patients enrolled had a history of previous use ... See full document
108
Fluvastatin in the therapy of acute coronary syndrome: Rationale and design of a multicenter, randomized, double blind, placebo controlled trial (The FACS Trial)[ISRCTN81331696]
... Previous controlled clinical trials reporting the positive effects of statins in participants with ACS were designed for very early secondary ...no controlled trials have evaluated the potential benefits of ... See full document
29
The effect of spironolactone on calcineurin inhibitor induced nephrotoxicity: a multicenter randomized, double-blind, clinical trial (the SPIREN trial)
... defined as a reduction of eGFR> 30% - however, this did not impact the relative mortality risk in this group. Inter- estingly, worsening renal function was associated with an increased adjusted mortality risk in the ... See full document
5
The efficacy and safety of Danggui Sayuk Ga Osuyu Saenggang tang on Korean patients with cold hypersensitivity in the hands: study protocol for a pilot, double blind, randomized, placebo controlled, parallel group clinical trial
... pilot, multicenter, double-blind, randomized, parallel-group, two-arm, placebo-controlled clinical ...a placebo control group, in a 1:1 ratio using a web-based ... See full document
6
Title: EMERGING TRENDS IN PHARMACEUTICALS: NANOTECHNOLOGY Author: Mr. Kashyap Nagariya Keyword: Guest EditorialPage No: i-iiDownload PDF
... with interferon beta leads to a reduction of neuron inflammation Moreover, it is also thought to increase the production of nerve growth factor and improve neuronal ...survival. Interferon therapy ... See full document
6
Profile of saxagliptin in the treatment of type 2 diabetes: focus on Japanese patients
... T2DM. Results similar to the above study were reported in the recent EXAMINE (EXamination of cArdiovascular outcoMes:AlogliptIN versus standard of carE in patients with type 2 diabetes mellitus and acute coronary ... See full document
476
New and emerging treatments for ulcerative colitis: a focus on vedolizumab
... continued into the open-label extension. A further 15 patients who had been in the placebo group enrolled in the extension. Eighty-one percent of these patients continued vedolizumab until day 547; five patients ... See full document
79
Pilocarpine application on treatment of xerostomia: state of the art
... primary biliary cirrhosis. It is also an adverse effect of several commonly prescribed drugs. Over 500 medications have been associated with dry mouth, such as tricyclic antidepressants, antipsychotics, decongestants, ... See full document
17
Galantamine-ER for the treatment of mild-to-moderate Alzheimer’s disease
... clinical study showed that basic pharmacokinetic parameters such as the area under the plasma concentration-time curve from time 0 to 24 hours (AUC 0–24 ), mean minimum predose plasma concentration (C min ), and mean ... See full document
12
Minocycline and celecoxib as adjunctive treatments for bipolar depression: a study protocol for a multicenter factorial design randomized controlled trial
... a multicenter, 3-month, randomized, placebo-controlled, double-blind, factorial design trial of minocycline and/or celecoxib added to TAU for the treatment of depressive ... See full document
64
Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, placebo-controlled, double-blind, multicenter trial
... be effective in reducing migraine symptoms when ad- ministered as prophylactic agents in episodic migraine ...ized, double-blind and controlled trial with a triple com- bination of ... See full document
16
Biologics in the treatment of psoriasis and emerging new therapies in the pipeline
... of the two major Phase II trials who received subcutaneous doses of either 25 mg twice weekly, 50 mg weekly, or 50 mg twice weekly maintained a DLQI response of greater than five-point improvement from baseline and 27.8% ... See full document
15
Profile of oral laquinimod and its potential in the treatment of multiple sclerosis
... The trial was a multicenter, double-blind, randomized study comparing two doses of laquinimod ...with placebo in 209 RRMS and secondary pro- gressive multiple sclerosis ... See full document
11
<p>Review Of The Safety, Efficacy And Tolerability Of Fingolimod In The Treatment Of Pediatric Patients With Relapsing-Remitting Forms Of Multiple Sclerosis (RRMS)</p>
... the randomized controlled PARADIGMS trial, 18 fi ngolimod experience in POMS population has been lim- ited to small observational ...and MRI data (including T2-weighted and gadolinium-enhancing ... See full document
26
Randomized trial of daily high-dose vitamin D3 in patients with RRMS receiving subcutaneous interferon β-1a
... a sufficient increase in 25(OH)D levels (>150 nmol/L) while remaining below levels leading to hypercalcemia (500 nmol/L). 21 As over-the-counter vitamin formulations often contain ≤25 μg vitamin D, we permitted patients ... See full document
10
Comparative efficacy of alemtuzumab and established treatment in the management of multiple sclerosis
... more effective than the injectable ...intramuscular interferon b -1a in one of its Phase III trials and demonstrated greater ...subcutaneous interferon b -1a in three clinical ...with ... See full document
46
Related subjects